サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683379

リハビリ用ロボット外骨格の世界市場：2025年～2033年

Global Robotic Exoskeletons for Rehabilitation Market - 2025-2033

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
リハビリ用ロボット外骨格の世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のリハビリテーション用ロボット外骨格の市場規模は、2024年に4億2,800万米ドルに達し、2033年には12億3,700万米ドルに達すると予測され、予測期間2025年にはCAGR12.5％で成長する見込みです。

リハビリ用ロボット外骨格は、脊髄損傷、脳卒中、神経疾患などによる移動の問題を抱える人々を支援するウェアラブルデバイスです。これらのデバイスは、ユーザーの体にフィットする軽量フレームを持ち、モーター、センサー、アクチュエーターを搭載しており、運動、特に歩行を支援します。利用者の体をサポートすることで、利用者はリハビリ運動に参加し、歩行能力を向上させ、日常生活の自立を得ることができます。

筋骨格系障害の有病率の上昇は、リハビリ用ロボット外骨格市場を大きく牽引すると予想されます。脊髄損傷、脳卒中、神経障害を含む筋骨格系の疾患は、しばしば運動機能に障害をもたらし、回復にはリハビリテーションが不可欠となります。筋骨格系障害を患う人の数は増加しています。

例えば、2023年の米国国立衛生研究所によると、約17億1,000万人が筋骨格系の疾患を抱えながら生活していると報告されています。世界の人口が高齢化し、これらの障害の発生率が上昇するにつれて、ロボット外骨格のような高度なリハビリテーションソリューションに対する需要が増加します。

個別化されたリハビリ治療へのニーズの高まりと、より効果的な回復オプションへの要望が、ロボット外骨格の採用をさらに後押ししています。より多くの患者が筋骨格系の障害に対する革新的な解決策を求める中、ロボット外骨格は機能性と独立性を回復させる効果的な方法を提供し、市場の成長を促進しています。

ロボット外骨格はコストが高いため、これらの機器のリハビリテーション市場の成長が大幅に制限される可能性があります。これらの外骨格は高度な技術、特殊な材料、複雑な工学技術で作られており、これらすべてが製造・購入コストを押し上げます。さらに、機器のメンテナンスや医療機関への使用訓練に関連する費用は、特に医療予算に制約のある地域では、多くの病院やリハビリ・センターにとって障壁となる可能性があります。その結果、ロボット外骨格の高価格が普及と使用を妨げる恐れがあります。

当レポートでは、世界のリハビリ用ロボット外骨格市場について調査し、市場の概要とともに、タイプ別、患者タイプ別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 リハビリ用ロボット外骨格市場、タイプ別

  • 下半身用外骨格
  • 上半身用外骨格
  • 全身用外骨格

第6章 リハビリ用ロボット外骨格市場、患者タイプ別

  • 障碍者
  • 小児
  • 高齢者

第7章 リハビリ用ロボット外骨格市場、用途別

  • 神経リハビリテーション
  • 脊髄損傷リハビリテーション
  • 整形外科リハビリテーション
  • その他

第8章 リハビリ用ロボット外骨格市場、エンドユーザー別

  • リハビリテーションセンター
  • 病院・クリニック
  • 孤児院
  • 在宅ケア

第9章 リハビリ用ロボット外骨格市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

第11章 企業プロファイル

  • Cyberdyne Care Robotics GmbH
  • BIONIK
  • ExoAtlet
  • Lifeward, Inc.
  • Gogoa.eu
  • German Bionic Systems GmbH
  • Siyi Intelligent Technology Co., Ltd.
  • Hocoma
  • Rex Bionics Ltd.
  • RoboCT

第12章 仮定と調査手法

第13章 付録

目次
Product Code: MD9319

The global robotic exoskeletons for rehabilitation market reached US$ 428 million in 2024 and is expected to reach US$ 1,237 million by 2033, growing at a CAGR of 12.5% during the forecast period 2025-2033.

Robotic exoskeletons for rehabilitation are wearable devices that help people with mobility issues, like those caused by spinal cord injuries, stroke, or neurological conditions. These devices have a lightweight frame that fits around the user's body and includes motors, sensors, and actuators to assist with movement, especially walking. They support the user's body, allowing patients to participate in rehabilitation exercises, improve their walking ability, and gain independence in their daily lives.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Musculoskeletal Disorders

The increasing prevalence of musculoskeletal disorders is expected to significantly drive the robotic exoskeletons for the rehabilitation market. Musculoskeletal conditions, including spinal cord injuries, stroke, and neurological disorders, often result in impaired mobility, making rehabilitation essential for recovery. There is a growing number of individuals suffering from musculoskeletal disorders.

For instance, according to the National Institute of Health in 2023, it is reported that approximately 1.71 billion people are living with a musculoskeletal condition. As the global population ages and the incidence of these disorders rises, the demand for advanced rehabilitation solutions like robotic exoskeletons increases.

The growing need for personalized rehabilitation treatments and the desire for more effective recovery options further boost the adoption of robotic exoskeletons. As more patients seek innovative solutions for musculoskeletal impairments, robotic exoskeletons provide an effective way to restore functionality and independence, driving growth in the market.

Stringent Regulatory Frameworks

The high costs of robotic exoskeletons could significantly limit the growth of the rehabilitation market for these devices. These exoskeletons are made with advanced technology, specialized materials, and intricate engineering, all of which drive up the production and purchase costs. Additionally, the expenses associated with maintaining the devices and training healthcare providers to use them can be barriers for many hospitals and rehabilitation centers, particularly in areas with constrained healthcare budgets. As a result, the steep price of robotic exoskeletons could prevent widespread adoption and use.

Segment Analysis

The global robotic exoskeletons for rehabilitation market is segmented based on the type, patient type, application, end-user and region.

Lower body exoskeletons in the type segment is expected to dominate the robotic exoskeletons for rehabilitation market

The lower body exoskeletons segment is expected to dominate the robotic exoskeletons for the rehabilitation market due to their significant ability to restore mobility and independence for individuals with lower limb impairments. A large number of individuals suffer and experience lower limbs, hip, and knee fractures, which require rehabilitation after a certain period.

For instance, according to a study by the National Institute of Health in 2024, the overall incidence of lower limb fractures was 215.9 lower limb long bone fractures per 100,000 patients per year. These devices, which help patients with conditions like spinal cord injuries, stroke, and neurological disorders regain the ability to walk and perform functional movements, are increasingly seen as essential for rehabilitation.

The growing focus on active rehabilitation over passive treatments is driving adoption, as lower body exoskeletons enable patients to engage in weight-bearing activities such as walking, standing, and even climbing stairs. These activities are vital for improving muscle strength, bone density, and overall recovery.

Additionally, continuous advancements in technology have made these devices more user-friendly, cost-effective, and efficient, further expanding their reach in healthcare settings. As a result, the segment is expected to dominate the market, driven by rising patient demand, clinical benefits, and ongoing technological innovations.

Geographical Analysis

North America is expected to dominate the robotic exoskeletons for rehabilitation market

North America is expected to maintain a dominant position in the robotic exoskeletons for the rehabilitation market, driven by several key factors. The region's advanced healthcare infrastructure plays a crucial role in facilitating the adoption of innovative technologies, such as robotic exoskeletons, particularly in the United States. The country dominates in both the development and implementation of these devices, supported by significant contributions from major companies and research institutions advancing robotic rehabilitation solutions.

Additionally, North America benefits from substantial healthcare expenditure, enabling hospitals and rehabilitation centers to invest in advanced equipment. Well-established health insurance systems that can cover the costs of medical devices, coupled with an increasing focus on rehabilitation therapies for patients with spinal cord injuries, strokes, and other mobility challenges, further support market growth.

Companies in the region are entering into strategic collaborations to expand and innovate advanced robotic exoskeletons for rehabilitation.

For instance, in May 2024, DIH Holding US, Inc. entered a strategic collaboration with B-Temia Inc. to drive AI-based innovation and smart solutions in the rehabilitation industry. This partnership combines B-Temia's expertise in AI-driven robotics with DIH's broad robotic portfolio, marking a significant step in improving functional rehabilitation and support in North America. Thus, the above factors are combinedly driving the region's growth and holding the region in a dominant position.

Competitive Landscape

The global market players in the robotic exoskeletons for rehabilitation market are Cyberdyne Care Robotics GmbH, BIONIK, ExoAtlet, Lifeward, Inc., Gogoa.eu, German Bionic Systems GmbH, Siyi Intelligent Technology Co., Ltd., Hocoma, Rex Bionics Ltd., and RoboCT, among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global robotic exoskeletons for rehabilitation market report would provide approximately 45 tables, 46 figures and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Patient Type
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Musculoskeletal Disorders
      • 3.1.1.2. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs Associated with the Robotic Exoskeletons
      • 3.1.2.2. Lack of Awareness
    • 3.1.3. Opportunity
      • 3.1.3.1. Expanding Applications
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Robotic Exoskeletons for Rehabilitation Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Lower Body Exoskeletons*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Upper Body Exoskeletons
  • 5.4. Full Body Exoskeletons

6. Robotic Exoskeletons for Rehabilitation Market, By Patient Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 6.1.2. Market Attractiveness Index, By Patient Type
  • 6.2. Disabled*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Pediatrics
  • 6.4. Elderly

7. Robotic Exoskeletons for Rehabilitation Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Neuro Rehabilitation*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Spinal Cord Injury Rehabilitation
  • 7.4. Orthopedic Rehabilitation
  • 7.5. Others

8. Robotic Exoskeletons for Rehabilitation Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Rehabilitation Centers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospitals & Clinics
  • 8.4. Orphanages
  • 8.5. Homecare

9. Robotic Exoskeletons for Rehabilitation Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Cyberdyne Care Robotics GmbH*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. BIONIK
  • 11.3. ExoAtlet
  • 11.4. Lifeward, Inc.
  • 11.5. Gogoa.eu
  • 11.6. German Bionic Systems GmbH
  • 11.7. Siyi Intelligent Technology Co., Ltd.
  • 11.8. Hocoma
  • 11.9. Rex Bionics Ltd.
  • 11.10. RoboCT

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us